Contrast-enhanced whole-heart MR coronary angiography at 3.0 T using the intravascular contrast agent gadofosveset

Invest Radiol. 2009 Jul;44(7):369-74. doi: 10.1097/rli.0b013e3181a40d1d.

Abstract

Objectives: The purpose of this study was to compare contrast-enhanced (CE) whole-heart coronary magnetic resonance angiography (MRA) at 3.0 T using gadofosveset to noncontrast-enhanced steady-state free precession (SSFP) coronary MRA at 1.5 T.

Materials and methods: A prospective randomized study was conducted among 20 healthy male volunteers. The same group of subjects underwent CE whole heart MRA at 3.0 T employing a 3D FLASH sequence with IR prepulse after gadofosveset injection as well as noncontrast-enhanced coronary MRA at 1.5 T using a 3D SSFP sequence with T2-preparation. Both techniques were performed using prospective ECG-triggering and adaptive respiratory gating. Acquisition time, signal-to-noise ratio of coronary blood, contrast-to-noise ratio (CNR) between coronaries and adjacent myocardium or epicardial fat, and image quality were evaluated in each case.

Results: A significant increase of the overall CNR between coronary blood and adjacent myocardium was measured on images acquired at 3 T in comparison to 1.5 T. The mean values were 38.9 +/- 19.6 and 26.3 +/- 15.4, respectively (P[r] < 0.005). There was no significant difference in CNR between coronary blood and epicardial fat. The mean image quality for the proximal and mid coronary segments was not statistically different between 1.5 T and 3.0 T (P > 0.05), however, the distal coronary segments were rated significantly higher for the CE MRA at 3.0 T (P = 0.02). The average acquisition time (15.29 +/- 5.73 minutes at 1.5 T vs. 17.29 +/- 5.18 minutes at 3 T) and overall image quality (2.15 +/- 0.49 at 1.5 T vs. 2.35 +/- 0.39 at 3 T) were similar for both methods.

Conclusions: CE whole-heart coronary MRA at 3.0 T demonstrated higher overall CNR between coronary blood and myocardium and an improved image quality of the distal coronary segments compared with noncontrast-enhanced SSFP coronary MRA at 1.5 T.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Animals
  • Contrast Media / administration & dosage
  • Coronary Angiography / methods*
  • Coronary Vessels / anatomy & histology*
  • Gadolinium / administration & dosage
  • Gadolinium / therapeutic use*
  • Heart / anatomy & histology*
  • Humans
  • Image Enhancement / methods*
  • Injections, Intravenous
  • Magnetic Resonance Angiography / methods*
  • Male
  • Organometallic Compounds / administration & dosage
  • Organometallic Compounds / therapeutic use*
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Contrast Media
  • Organometallic Compounds
  • Gadolinium
  • gadofosveset trisodium